๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Breast cancer developing in four women cured of Hodgkin's disease

โœ Scribed by Robert W. Carey; Rita M. Linggood; William Wood; Peter H. Blitzer


Publisher
John Wiley and Sons
Year
1984
Tongue
English
Weight
348 KB
Volume
54
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Breast cancer after hodgkin's disease in
โœ Frederick P. Li; Joseph Corkery; George Canellos; Harvey W. Neitlich ๐Ÿ“‚ Article ๐Ÿ“… 1981 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 322 KB ๐Ÿ‘ 2 views

Two sisters had breast cancer at four years and I1 years after diagnosis of Hodgkin's disease. The affected breast tissues had received several hundred rads of scatter radiation during treatment of the lymphoma. Family history revealed breast cancer in a third sister and five other women in the pate

High risk of breast carcinoma after irra
โœ Alan C. Aisenberg; Dianne M. Finkelstein; Karen P. Doppke; Frederick C. Koerner; ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 98 KB ๐Ÿ‘ 2 views

## Background: Treatment-associated second neoplasms have emerged as a major threat to the continued survival of patients cured of hodgkin's disease. in this study, the authors investigated the risk of breast carcinoma in an irradiated hodgkin's disease population. ## Methods: One hundred and ele

Risk of new cancers in patients with Hod
โœ James C. Arseneau; George P. Canellos; Ralph Johnson; Vincent T. Devita Jr. ๐Ÿ“‚ Article ๐Ÿ“… 1977 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 453 KB ๐Ÿ‘ 2 views
Clinical development of estrogen modulat
โœ Julia A. Lawrence; Phyllis B. Malpas; Caroline C. Sigman; Gary J. Kelloff ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 103 KB ๐Ÿ‘ 2 views

Tamoxifen has proven to be beneficial in the chemoprevention of breast cancer in women at increased risk for the disease. Other compounds that mediate the estrogen pathway remain to be tested for clinical efficacy. The mechanism of action, efficacy, and dose response of the estrogen modulators is de